Difference between revisions of "Clinical Applications and Biological Targets Subcommittee"
Jump to navigation
Jump to search
m (→Call Summaries) |
m (→Call Summaries) |
||
| Line 11: | Line 11: | ||
==Call Summaries== | ==Call Summaries== | ||
| + | *[[Media:11 09 2012 QIBA US SWS Clinical Applications-DRAFT-DC.pdf |11.09.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
*[[Media:10 22 2012 QIBA US SWS Clinical Applications-DRAFT-DC.pdf |10.22.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary - DC]] | *[[Media:10 22 2012 QIBA US SWS Clinical Applications-DRAFT-DC.pdf |10.22.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary - DC]] | ||
*[[Media:10.01.2012 QIBA US SWS Clinical Applications SC - FINAL2.pdf |10.01.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | *[[Media:10.01.2012 QIBA US SWS Clinical Applications SC - FINAL2.pdf |10.01.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
Revision as of 21:27, 17 December 2012
Draft Charge
Reference Materials
Presentations and Reports
Call Summaries
- 11.09.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 10.22.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary - DC
- 10.01.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 09.10.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 08.13.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 07.23.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary